Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Schiffer

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Neuro-Oncology|January 31, 2012
MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumorsMarta Mellai, Oriana Monzeglio, Angela Piazzi, et al.
Cells|July 1, 2020
Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade GliomasMarta Mellai, Laura Annovazzi, Ilaria Bisogno, et al.
Plos One|June 16, 2012
REST controls self-renewal and tumorigenic competence of human glioblastoma cellsLuciano Conti, Laura Crisafulli, Valentina Caldera, et al.
Neuro-Oncology|July 31, 2013
Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathwayChiara Riganti, Iris Chiara Salaroglio, Valentina Caldera, et al.
The Journal of Biological Chemistry|December 7, 2013
Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acidMonica Cattaneo, Simona Baronchelli, Davide Schiffer, et al.
Oncotargets and Therapy|March 5, 2015
Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?Marta Mellai, Angela Piazzi, Cristina Casalone, et al.
Oncotarget|December 7, 2017
Comparison among conventional and advanced MRI, <sup>18</sup>F-FDG PET/CT, phenotype and genotype in glioblastomaMaria Consuelo Valentini, Marta Mellai, Laura Annovazzi, et al.
Molecular Pharmaceutics|July 3, 2019
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem CellsIris Chiara Salaroglio, Carmen Abate, Barbara Rolando, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2013
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signalingChiara Riganti, Iris C Salaroglio, Martha L Pinzòn-Daza, et al.
Comparative Medicine|April 7, 2017
Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic EvaluationElena Biasibetti, Alberto Valazza, Maria T Capucchio, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|January 31, 2012
MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumorsMarta Mellai, Oriana Monzeglio, Angela Piazzi, et al.
Cells|July 1, 2020
Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade GliomasMarta Mellai, Laura Annovazzi, Ilaria Bisogno, et al.
Plos One|June 16, 2012
REST controls self-renewal and tumorigenic competence of human glioblastoma cellsLuciano Conti, Laura Crisafulli, Valentina Caldera, et al.
Neuro-Oncology|July 31, 2013
Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathwayChiara Riganti, Iris Chiara Salaroglio, Valentina Caldera, et al.
The Journal of Biological Chemistry|December 7, 2013
Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acidMonica Cattaneo, Simona Baronchelli, Davide Schiffer, et al.
Oncotargets and Therapy|March 5, 2015
Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?Marta Mellai, Angela Piazzi, Cristina Casalone, et al.
Oncotarget|December 7, 2017
Comparison among conventional and advanced MRI, <sup>18</sup>F-FDG PET/CT, phenotype and genotype in glioblastomaMaria Consuelo Valentini, Marta Mellai, Laura Annovazzi, et al.
Molecular Pharmaceutics|July 3, 2019
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem CellsIris Chiara Salaroglio, Carmen Abate, Barbara Rolando, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2013
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signalingChiara Riganti, Iris C Salaroglio, Martha L Pinzòn-Daza, et al.
Comparative Medicine|April 7, 2017
Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic EvaluationElena Biasibetti, Alberto Valazza, Maria T Capucchio, et al.
Pageof 6